Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The protein encoded by TNFRSF8 is a member of the TNF-receptor superfamily. Zusätzlich bieten wir Ihnen TNFRSF8 Kits (32) und TNFRSF8 Proteine (20) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 686 products:
Human Monoclonal TNFRSF8 Primary Antibody für FACS, IHC (p) - ABIN94067
Pavlov, Martins, Delgado: Development and validation of a fluorescent microsphere immunoassay for soluble CD30 testing. in Clinical and vaccine immunology : CVI 2009
Zeige alle 7 Referenzen für 94067
Mouse (Murine) Monoclonal TNFRSF8 Primary Antibody für FACS - ABIN370913
Bowen, Lee, Miragliotta, Nam, Podack: Structure and expression of murine CD30 and its role in cytokine production. in Journal of immunology (Baltimore, Md. : 1950) 1996
Zeige alle 3 Referenzen für 370913
Mouse (Murine) Monoclonal TNFRSF8 Primary Antibody für FACS - ABIN370914
Falini, Pileri, Pizzolo, Dürkop, Flenghi, Stirpe, Martelli, Stein: CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. in Blood 1995
Zeige alle 3 Referenzen für 370914
Human Polyclonal TNFRSF8 Primary Antibody für ELISA, IHC (p) - ABIN1997473
Ekström, Bengtsson, Svensson, Nilsson, Ostlund, Sandstedt, Bremme, Lilja, Scheynius: Presence of CD30(+) and CD30L(+) cells in human placenta and soluble CD30 levels in cord blood are independent of maternal atopy. in Placenta 2001
Zeige alle 2 Referenzen für 1997473
Human Monoclonal TNFRSF8 Primary Antibody für EIA, FACS - ABIN118590
Dürkop, Latza, Hummel, Eitelbach, Seed, Stein: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. in Cell 1992
Zeige alle 2 Referenzen für 118590
Human Monoclonal TNFRSF8 Primary Antibody für FACS, ELISA - ABIN969019
Kamali, Abbasi, Farokhi, Abbasi, Fallah, Seifee, Ghadimi, Rezaie: Posttransplant soluble CD30 as a predictor of acute renal allograft rejection. in Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2010
This study demonstrated the amelioration of MOG35-55 peptide-induced active EAE in CD30 KO mice. CD30 was expressed limitedly on CD4 (zeige CD4 Antikörper) T cells at the induction phase of experimental autoimmune encephalomyelitis.
Data indicate that CD30L (zeige TNFSF8 Antikörper)/CD30 axis plays a modulatory role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE).
role in the maintenance and activation of IL-17A (zeige IL17A Antikörper)-producing gammadelta T cells
These results suggest that CD30 signaling plays an important role in the activation of IL-17A (zeige IL17A Antikörper)-producing Vgamma1(-) Vgamma4(-) gammadelta T cells bearing Vgamma6 at an early stage of BCG (zeige SLC11A1 Antikörper) infection.
Interference of the CD30-CD30L (zeige TNFSF8 Antikörper) pathway reduces atherosclerosis development.
CD30L (zeige TNFSF8 Antikörper)/CD30 pathway acts as an accelerator of enteritis in a murine disease model
role of CD30L (zeige TNFSF8 Antikörper)/CD30 interactions in allergic rhinitis; results suggest that CD30L (zeige TNFSF8 Antikörper) plays an important role in allergic rhinitis
Abrogation of CD30 and OX40 (zeige TNFRSF4 Antikörper) signals prevents autoimmune disease in FoxP3 (zeige FOXP3 Antikörper)-deficient mice.
Studies demonstrate that CD30L (zeige TNFSF8 Antikörper)/CD30 signaling executed by the T-T cell interaction plays a critical role in Th17 cell differentiation.
CD30 can signal in a completely TCR-independent fashion to induce IL-13 (zeige IL13 Antikörper) production by effector T cells.
Prevalence of the CD30 (Ki-1) antigen in human solid tumors was summarized.
CD30 expression was detected in up to 25% of cases of diffuse large B-cell lymphoma and was more frequent in tumors without MYC (zeige MYC Antikörper) rearrangement. CD30 expression was not associated with overall survival in R-EPOCH-treated de novo DLBCL patients.
CD30 facilitates phosphorylation of heat shock factor 1, activates heat shock promoter element, and induces heat shock protein (HSP) 90 (zeige HSP90AA1 Antikörper).
this study shows that polyclonal and allogeneic stimulation induced higher levels of CD30 transcripts in end-stage renal disease patients compared to control patients
CD30 expression was not associated with prognosis in our cohort of de novoDLBCL, including in patients who received aggressive chemotherapy. CD30 expression and MYC (zeige MYC Antikörper) rearrangement were mutually exclusive in de novoDLBCL.
Case Report: CD30 positive lymphomatoid papulosis arising in association with cutaneous amyloidosis in a patient with multiple myeloma.
The heterogeneity of CD30 expression in refractory or relapsed peripheral T-cell lymphoma patients indicates the likelihood for better response for patients with strong CD30 expression by tumor cells.
CD30 may be useful as a prognostic marker in rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP (zeige DDIT3 Antikörper)) treated DLBCLs, indicating favorable outcomes in a Chinese population.
this review is focused on the role of CD30 receptor and p53 (zeige TP53 Antikörper) as novel targets for therapy in ALK (zeige ALK Antikörper)+ ALCL, and also provides an update on their potential involvement in ALK (zeige ALK Antikörper)+ ALCL pathogenesis
Most angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma-not otherwise specified express variable levels of CD30.
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.
tumor necrosis factor receptor superfamily member 8
, tumor necrosis factor receptor superfamily, member 8
, tumor necrosis factor ligand superfamily member 8
, tumor necrosis factor receptor superfamily member 8-like
, CD30L receptor
, lymphocyte activation antigen CD30
, Ki-1 antigen
, cytokine receptor CD30
, Tumor necrosis factor superfamily member 8
, tumor necrosis factor superfamily, member CD30